Henan Wild Medical Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Henan Wild Medical Technology Co., Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 28 (Toys & Sporting Goods) across 2 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include WILD+. The owner is based in Zhengzhou, Henan.
701-702, Greenland Century Plaza,
No.12 Shangwuwaihuan Road,
Zhengzhou, Henan 450000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Henan Wild Medical Technology Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Henan Wild Medical Technology Co., Ltd. have?
Henan Wild Medical Technology Co., Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending.
What trademark classes does Henan Wild Medical Technology Co., Ltd. file in?
Henan Wild Medical Technology Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 28 (Toys & Sporting Goods). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Henan Wild Medical Technology Co., Ltd.'s most well-known trademarks?
Henan Wild Medical Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as WILD+. These are among 1 currently registered trademark in the portfolio.
What is Henan Wild Medical Technology Co., Ltd.'s trademark registration success rate?
Henan Wild Medical Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 2 applications are pending review.